India pulled back its supply of vaccines to the rest of the world after the second wave of pandemic hit the country, resulting in acute global shortage of COVID-19 vaccines. When the Delta variant is raging around the world and supply is lacking globally because the Serum Institute of India pulled back hundreds of millions of vaccines that were supposed to go to COVAX because Europe is still in the throes of the pandemic, hopefully coming out of it now with light at the end of the tunnel.


  1. COVAX is in the position it's in because India has had to pull back so much supply that had been intended to go for second shots and for health workers.
  2. COVAX has found itself in this third quarter in a really difficult pinch. That's going to change when the Pfizer doses start coming online in August.
  3. COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi and the World Health Organization (WHO), alongside key delivery partner UNICEF.
  4. Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world.
  5. So COVAX has found itself in this period in a very difficult spot. It's the poorest countries in the world.